Andrea Mignatti

Andrea Mignatti

Interventional Cardiology

3400 Bainbridge Avenue
7th Floor Area B
Bronx, NY 10467

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Clinical Experience With a Novel Percutaneous LV Assist Device in High-Risk PCI: Primary Results From the SUPPORT I Study.

Clinical Experience With a Novel Percutaneous LV Assist Device in High-Risk PCI: Primary Results From the SUPPORT I Study.

Journal: Circulation. Cardiovascular interventions

Published: May 05, 2026

Utilization of Intracoronary Ultrasound Enhancing Agent to Confirm Type 4 Coronary Perforation.

Utilization of Intracoronary Ultrasound Enhancing Agent to Confirm Type 4 Coronary Perforation.

Journal: JACC. Case reports

Published: March 21, 2025

State of the Art of Primary PCI: Present and Future.

State of the Art of Primary PCI: Present and Future.

Journal: Journal of clinical medicine

Published: November 18, 2024

Clinical Presentation and Percutaneous Treatment of Hemolytic Anemia Associated With Paravalvular Leak After TAVR.

Clinical Presentation and Percutaneous Treatment of Hemolytic Anemia Associated With Paravalvular Leak After TAVR.

Journal: JACC. Case reports

Published: July 09, 2024

A novel therapy in microvascular obstruction in ST-elevation myocardial infarction: pressure-controlled intermittent coronary sinus occlusion therapy.

A novel therapy in microvascular obstruction in ST-elevation myocardial infarction: pressure-controlled intermittent coronary sinus occlusion therapy.

Journal: Future cardiology

Published: November 07, 2023

A technology evaluation of the Onyx Frontier drug-eluting stent.

A technology evaluation of the Onyx Frontier drug-eluting stent.

Journal: Expert opinion on drug delivery

Published: May 19, 2023

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.

Journal: JAMA internal medicine

Published: October 07, 2021

Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.

Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.

Journal: Thrombosis and haemostasis

Published: April 06, 2021

Deep Vein Thrombosis of the Left Leg: A Case of May-Thurner Syndrome.

Deep Vein Thrombosis of the Left Leg: A Case of May-Thurner Syndrome.

Journal: European journal of case reports in internal medicine

Published: December 19, 2017

Targeting the safe zone: A quality improvement project to reduce vascular access complications.

Targeting the safe zone: A quality improvement project to reduce vascular access complications.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: January 18, 2016

From door-to-balloon time to contact-to-device time: predictors of achieving target times in patients with ST-elevation myocardial infarction.

From door-to-balloon time to contact-to-device time: predictors of achieving target times in patients with ST-elevation myocardial infarction.

Journal: Clinical cardiology

Published: January 23, 2014

Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failure.

Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failure.

Journal: JACC. Heart failure

Published: October 09, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026